Twenty years ago, as part of a review of the clinical pharmacology of mild analgesics (Beaver, 1965, 1966), I evaluated reports of those analgesic trials of dextropropoxyphene that appeared to satisfy the minimum methodologic requirements for a controlled clinical trial of analgesic efficacy. On reviewing reports of studies that have been published since then, I find little need to modify my evaluation of the efficacy of dextropropoxyphene that appeared in 1966, at least in respect to the effect of single oral doses:
In summary, dextropropoxyphene (hydrochloride) is a mild oral analgesic which has proven superior to placebo in doses of 65 mg or more but which is of questionable efficacy in doses lower than 65 mg. The drug is definitely less potent than codeine: the best available estimates of the relative potency of the two drugs indicating that dextropropoxyphene is approximately 1/2-2/3 as potent. Likewise, dextropropoxyphene in 32-65 mg doses is certainly no more, and possibly less, effective than the usually used doses of aspirin or A.P.C. (aspirin/phenacetin/caffeine).
In the interim, the efficacy of dextropropoxyphene has been the subject of a number of other critical reviews (Miller et al., 1970; Miller, 1977), commentaries (Kiplinger & Nickander, 1971; Lasagna, 1976), and even congressional hearings (Beaver, 1979; Moertel, 1979). More importantly, new controlled clinical trials involving dextropropoxyphene hydrochloride or napsylate have been reported, and some of these use more sophisticated design and analysis than those available in 1966. I will therefore discuss the results of those newer studies of apparently suitable scientific design that meet at least the minimum criteria for a valid clinical assay of analgesic activity (Beaver, 1965; Houde et al., 1965,1966; Wallenstein & Houde, 1975; Beaver, 1983), and I will comment on only a few of the studies included in my previous review (Beaver, 1966).
Get full access to this article
View all access options for this article.
References
1.
Baptisti, A., JR, GRUBER, C. M., JR & SANTOS, E. L. (1971). The effectiveness and side-effect liability of propoxyphene hydrochloride and propoxyphene napsylate in patients with postpartum uterine cramping. Toxicol. Appl. Pharmacol.,19, 519-527.
2.
Bauer, R.O., Baptisti, A., JR & Gruber, C.M., JR (1974). Evaluation of propoxyphene napsylate compound in post partum uterine cramping. J. Med., 5, 317-328.
3.
Beaver, W.T. (1965). Mild analgesics: a review of their clinical pharmacology (Part I). Am. J. Med. Sci., 250,577-604.
4.
Beaver, W.T. (1966). Mild analgesics: a review of their clinical pharmacology (Part II). Am. J. Med. Sci., 251,576-599.
5.
Beaver, W.T. (1975). Analgesic combinations. In Combination Drugs: Their Use andRegulation, pp. 52-72. New York: Stratton Intercon.
6.
Beaver, W.T. (1979). Statement on the efficacy and safety of propoxyphene (Darvon). In Safety, Efficacy, and Usefulness of Darvon and Other Preparations Containing Propoxyphene. Hearings before the Select Committee on Small Business of the United States Senate, 96th Congress, First Session. Part 34, pp. 16746-16772. Washington, DC: US Government Printing Office.
7.
Beaver. W.T. (1981). Aspirin and acetaminophen as constituents of analgesic combinations. Arch. Intern. Med., 141, 293-300.
8.
Beaver, W.T. (1983). Measurement of analgesic efficacy in man. In Advances in Pain Research and Therapy, vol. 5, pp. 411-434. New York: Raven Press.
9.
Beaver, W.T. & Feise, G.A. (1977). Twin crossover relative potency analgesic assays in man. I. Morphine vs. morphine. J. Clin. Pharmacol., 17, 461-479.
10.
Beaver, W.T. & McMullan, D. (1980). Methodological considerations in the evaluation of analgesic combinations: acetaminophen (paracetamol) and hydrocodone in postpartum pain. Br. J. Clin. Pharmacol., 10, 215S-223S.
11.
Beaver, W.T., Forbes, J.A. & Shackleford, R.W. (1983). A method for the 12-hour evaluation of analgesic efficacy in outpatients with postoperative oral surgery pain: three studies of diflunisal. Pharmacotherapy, 3, 23S-37S.
12.
Beaver, W.T., Wallenstein, S.L., Houde, R.W. & Rogers, A. (1966). A comparison of the analgesic effects of pentazocine and morphine in patients with cancer. Clin. Pharmacol. Ther. , 7, 740-751.
13.
Bedi, S.S. (1969). Comparison of aspirin and dextropropoxyphene-with-aspirin as analgesics in rheumatoid arthritis. Br. J. Clin. Pract. , 23, 413-417.
14.
Beecher, H.K., Keats, A.S., Mosteller, F. & Lasagna, L. (1953). The effectiveness of oral analgesics (morphine, codeine, acetylsalicyclic acid) and the problem of placebo 'reactors' and 'non-reactors'. J. Pharmacol. Exp. Ther., 109, 393-400.
15.
Berry, F.N., Miller, J.M., Levin, H.M., Bare, W.W., Hopkinson, J.H. & Feldman, A.J. (1975). Relief of severe pain with acetaminophen in a new dose formulation versus propoxyphene hydrochloride 65 mg and placebo: a comparative double-blind study. Curr. Ther. Res., 17, 361-368.
16.
Bloomfield, S.S., Barden, T.P. & Mitchell, J. (1976). Aspirin and codeine in two postpartum pain models . Clin. Pharmacol. Ther., 20, 499-503.
17.
Bloomfield, S.S., Barden, T.P. & Mitchell, J. (1980). Nefopam and propoxyphene in episiotomy pain. Clin. Pharmacol. Ther., 27, 502-507.
18.
Brooke, J.W. & Brooke, R.D. (1966). The anti-rheumatic effect of Darvon. West. Med., 7, 133-134.
19.
Cooper, S.A. (1981). Comparative analgesic efficacies of aspirin and acetaminophen. Arch. Intern. Med., 141, 282-285.
Cooper, S.A. & Beaver, W.T. (1976). A model to evaluate mild analgesics in oral surgery outpatients. Clin. Pharmacol. Ther., 20, 241-250.
22.
Cooper, S.A., Breen, J.F. & Giuliani, R.L. (1981). The relative efficacy of indoprofen compared with opioid-analgesic combinations. J. Oral Surg., 39, 21-25.
23.
Coutinho, A., Bonelli, J. & De Carvalho, P.C.N. (1976). A double-blind comparative study of the analgesic effects of fenbufen, codeine, aspirin, propoxyphene and placebo. Curr. Ther. Res., 19,58-65.
24.
Forbes, J.A., Butterworth, G.A., Burchfield, W.H., Beaver, W.T. & Shackleford, R.W. (1983). A 12-hour evaluation of the analgesic efficacy of diflunisal, zomepirac sodium, aspirin, and placebo in postoperative oral surgery pain. Pharmacotherapy, 3, 38S-46S.
25.
Forbes, J.A., Foor, V.M., Bowser, M.W., Calderazzo, J.P., Shackleford, R.W. & Beaver, W.T. (1982). A 12-hour evaluation of the analgesic efficacy of diflunisal, propoxyphene, a propoxyphene-acetaminophen combination, and placebo in postoperative oral surgery pain. Pharmacotherapy , 2, 43-49.
26.
Forrest, W.H., JR (1970). Report of the Veterans Administration Cooperative Analgesic Study. Minutes of the 32nd meeting of the Committee on Problems of DrugDependence, pp. 6957-6989.
27.
Gram, L.F., SCHOU, J., WAY, W. L., HELTBERG, J. & BODIN, N. O. (1979). d-Propoxyphene kinetics after single oral and intravenous doses in man. Clin. Pharmacol. Ther., 26,473-482.
28.
Gruber, C.M., JR (1957). Codeine phosphate, propoxyphene hydrochloride, and placebo. JAMA, 164, 966-969.
29.
Gruber, C.M., JR (1976). Evaluating interactions between fenoprofen and proxpoxyphene: analgesia and adverse reports by postepisiotomy patients. J. Clin. Pharmacol.,16, 407-417.
30.
Gruber, C.M., JR (1977). Codeine and propoxyphene in postepisiotomy pain: a two-dose evaluation. JAMA, 237, 2734-2735.
31.
Gruber, C.M., JR, BAPTISTI, A., JR & KIPLINGER, G. F. (1971a). Relief of postpartum uterine cramping with propoxyphene and aspirin. Toxicol. Appl. Pharmacol.,19, 546-553.
Gruber, C.M., JR, Wolen, R.L. & Baptisti, A., JR (1971c). Analgesia scores as timed responses following oral administration of propoxyphene to postpartum patients. Toxicol. Appl. Pharmacol.,19, 504-511.
34.
Gruber, C.M., JR, Miller, C.L., Finneran, J. & Chernish, S.M. (1956). The effectiveness of d-propoxyphene hydrochloride and codeine phosphate as determined by two methods of clinical testing for relief of chronic pain. J. Pharmacol. Exp. Ther ., 118, 280-285.
35.
Hopkinson, J.H. (1980). Ibuprofen versus propoxyphene hydrochloride and placebo in the relief of postepisiotomy pain. Curr. Ther. Res., 27, 55-63.
36.
Hopkinson, J.H., Bartlett, F.H., JR, Steffens, A.O., McGlumphy, T.H., Macht, E.L. & Smith, M. (1973). Acetaminophen versus propoxyphene hydrochloride for relief of pain in episiotomy patients. J. Clin. Pharmacol .,13, 251-263.
37.
Houde, R.W., Wallenstein, S.L. & Beaver, W.T. (1965). Clinical measurement of pain. In Analgesics, pp. 75 -122. New York: Academic Press.
38.
Houde, R.W., Wallenstein, S.L. & Beaver, W.T. (1966). Evaluation of analgesics in patients with cancer pain. In Clinical Pharmacology-Section 6 of the International Encyclopedia of Pharmacology and Therapeutics, pp. 59-97. New York: Pergamon Press.
39.
Huskisson, E.C. (1974). Simple analgesics for arthritis. Br. Med. J., iv, 196-200.
40.
Kantor, T.G., Sunshine, A., Laska, E., Meisner, M. & Hopper, M. (1966). Oral analgesic studies: pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placebo. Clin. Pharmacol. Ther., 7, 447-454.
41.
Kiplinger, G.F. & Nickander, R. (1971). Pharmacologic basis for use of propoxyphene. JAMA, 216, 289-292.
42.
Larkin, R.M., Van Orden, D.E., Poulson, A.M. & Scott, J.R. (1979). Dysmenorrhea: treatment with an antiprostaglandin . Obstet. Gynecol., 54, 456-460.
43.
Lasagna, L. (1976). Propoxyphene napsylate. Ann. Intern. Med., 85, 619-621.
44.
Laska, E.M., Sunshine, A., Mueller, F., Elvers, W.B., Siegel, C. & Rubin, A. (1984). Caffeine as an analgesic adjuvant. JAMA, 251, 1711-1718.
45.
Messick, R.T. (1979). Evaluation of acetaminophen, propoxyphene and their combination in office practice. J. Clin. Pharmacol. , 19, 227-230.
46.
Miller, R.R. (1977). Propoxyphene: a review. Am. J. Hosp. Pharm., 34, 413-423.
47.
Miller, R.R., Feingold, A. & Paxinos, J. (1970). Propoxyphene hydrochloride: a critical review . JAMA, 213, 996-1006.
48.
Modell, W. & Houde, R.W. (1958). Factors influencing clinical evaluation of drugs with special reference to the double blind-technique. JAMA , 167, 2190-2198.
49.
Moertel, C.G. (1976). Relief of pain with oral medications. Aust. N.Z. J. Med., 6, 1-8.
50.
Moertel, C.G. (1979). Statement before the Select Committee on Small Business, U.S. Senate. In Safety, Efficacy, and Usefulness of Darvon and Other Preparations ContainingPropoxyphene. Hearings before the Select Committee on Small Business of the United States Senate, 96th Congress, First Session. Part 34, pp. 16632-16650. Washington, DC: US Government Printing Office.
51.
Moertel, C.G., Ahmann, D.L., Taylor, W.F. & Schwartau, N. (1972). A comparative evaluation of marketed analgesic drugs. N. Engl. J. Med., 286, 813-815.
52.
Moertel, C.G., Ahmann, D.L., Taylor, W.F. & Schwartau, N. (1974). Relief of pain by oral medications: a controlled evaluation of analgesic combinations. JAMA, 229, 55-59.
Owen, M. & Hills, L.J. (1980). How safe is propoxyphene?Med. J. Aust., 1, 617-618.
55.
Sadove, M.S., Schiffrin, M.J. & Ali, S.M. (1961). A controlled study of codeine, dextropropoxyphene and RO 4-1778/1. Am. J. Med. Sci., 241,103-108.
56.
Strumia, E. & Babbini, M. (1973). A comparative evaluation of mefenamic acid, propoxyphene, flufenisal and placebo in osteoarticular pain. J. Int. Med. Res., 1, 258-260.
57.
Sunshine, A. & Kantor, T.G. (1966). Oral analgesic compounds in post-surgical pain: a study of Bandol (SQ 10, 269) at Bellevue Hospital. Minutes of the 28th meeting of the Committee on Problems of Drug Dependence , Appendix 30, pp. 4764-4768.
58.
Sunshine, A., Laska, E. & Slafta, J. (1970). A comparison of the analgesic effects of Tramadol (Upjohn U-26, 225A) and propoxyphene HCl. Minutes of the 32nd meeting of the Committee on Problems of Drug Dependence, pp. 6902-6904.
59.
Sunshine, A., Slafta, J. & Gruber, C., JR (1978). A comparative analgesic study of propoxyphene, fenoprofen, the combination of propoxyphene and fenoprofen, aspirin, and placebo. J. Clin. Pharmacol.,18, 556-563.
60.
Sunshine, A., Laska, E., Slafta, J. & Fleischman, E. (1971). A comparative analgesia study of propoxyphene hydrochloride, propoxyphene napsylate, and placebo. Toxicol. Appl. Pharmacol., 19, 512-518.
61.
Waife, S.O., Gruber, C.M., JR, Rodda, B.E. & Nash, J.F. (1975). Problems and solutions to single-dose testing of analgesics: comparison of propoxyphene, codeine, and fenoprofen. Int. J. Clin. Pharmacol., 12, 301-304.
62.
Wallenstein, S.L. & Houde, R.W. (1975). The clinical evaluation of analgesic effectiveness . In Methods in Narcotics Research, pp. 127-145. New York: Marcel Dekker.
63.
Wang, R.I.H. (1974). A controlled clinical comparison of the analgesic efficacy of ethoheptazine, propoxyphene and placebo. Eur. J. Clin. Pharmacol., 7,183-185.
64.
Wang, R.I.H. & Sandoval, R.G. (1971). The analgesic activity of propoxyphene napsylate with and without aspirin. J. Clin. Pharmacol., 11, 310-317.
65.
Winter, L., JR, Calman, H.I., Caruso, W.A. & Post, A. (1973). A double-blind comparison of ethoheptazine citrate, propoxyphene hydrochloride, and placebo. Curr. Ther. Res. , 15, 383-390.
66.
Wolen, R.L., Ziege, E.A. & Gruber, C.M., JR (1975). Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography. Clin. Pharmacol. Ther., 17, 15-20.
67.
Wolen, R.L., Gruber, C.M., JR, Kiplinger, G.F. & Scholz, N.E. (1971a). Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration. Toxicol. Appl. Pharmacol., 19, 480-492.
68.
Wolen, R.L., Gruber, C.M., JR, Kiplinger, G.F. & Scholz, N.E. (1971b). Concentration of propoxyphene in human plasma following repeated oral doses. Toxicol. Appl. Pharmacol.,19, 493-497.
69.
Young, R.E.S. (1978). A two-dose evaluation of propoxyphene napsylate and codeine in postoperative pain. Curr. Ther. Res., 24, 495-502.
